CRNX icon

Crinetics Pharmaceuticals
CRNX

Overview Fund Activity

171 hedge funds and large institutions have $2.04B invested in Crinetics Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 81 increasing their positions, 29 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
171
Holders Change
+31
Holders Change %
+22.14%
% of All Funds
2.73%
Holding in Top 10
13
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+116.67%
% of All Funds
0.21%
New
51
Increased
81
Reduced
29
Closed
19
Calls
$31.7M
Puts
$33.7M
Net Calls
-$1.96M
Net Calls Change
-$1.54M

Top Buyers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$126M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$76.7M
3
CAM
3
Cormorant Asset Management
Massachusetts
$32.8M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$63.7M
5
Jennison Associates
5
Jennison Associates
New York
$42.6M

Top Sellers

1
O
1
OrbiMed
New York
$86.1M
2
BCLSI
2
Bain Capital Life Sciences Investors
Massachusetts
$37.9M
3
PA
3
Perceptive Advisors
New York
$37.6M
4
FC
4
Finepoint Capital
Massachusetts
$0
5
OM
5
Opaleye Management
Massachusetts
$11M
Name Holding Trade Value Shares
Change 		Shares
Change %
APM
26
Avidity Partners Management
Texas
$18.1M +$18.1M +610,000 New
Northern Trust
27
Northern Trust
Illinois
$17.8M +$3.17M +106,594 +22%
Janus Henderson Group
28
Janus Henderson Group
United Kingdom
$17.5M +$3.49M +117,642 +25%
Goldman Sachs
29
Goldman Sachs
New York
$16.4M -$1.85M -62,248 -10%
Morgan Stanley
30
Morgan Stanley
New York
$15.2M -$6.98M -234,838 -31%
CC
31
Commodore Capital
New York
$14.9M +$14.9M +500,000 New
Bank of New York Mellon
32
Bank of New York Mellon
New York
$14.6M +$851K +28,629 +6%
GKIM
33
GW&K Investment Management
Massachusetts
$14.4M -$3.06M -102,798 -18%
MB
34
MPM BioImpact
Massachusetts
$14.2M – – –
5VM
35
5AM Venture Management
California
$13.7M -$11.9M -400,000 -46%
Charles Schwab
36
Charles Schwab
California
$13.7M +$3.29M +110,565 +32%
AAA
37
Affinity Asset Advisors
New York
$13.4M +$13.4M +450,000 New
Walleye Capital
38
Walleye Capital
New York
$12.9M +$3.61M +121,312 +39%
Nuveen Asset Management
39
Nuveen Asset Management
Illinois
$12.2M +$2.02M +67,762 +20%
Two Sigma Investments
40
Two Sigma Investments
New York
$12M +$9.23M +310,418 +339%
Ensign Peak Advisors
41
Ensign Peak Advisors
Utah
$11.4M +$3.4M +114,416 +42%
OM
42
Opaleye Management
Massachusetts
$11M -$14.1M -475,000 -56%
FCM
43
Farallon Capital Management
California
$10.8M +$10.8M +361,904 New
VC
44
Vivo Capital
California
$10.4M +$10.4M +350,000 New
LCM
45
Laurion Capital Management
New York
$10.3M +$10.3M +346,637 New
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
$9.04M +$7.29M +244,960 +414%
Millennium Management
47
Millennium Management
New York
$8.4M +$7.14M +240,071 +565%
SSA
48
Schonfeld Strategic Advisors
New York
$8.24M +$8.24M +277,208 New
ACM
49
Altium Capital Management
New York
$7.79M +$3.78M +127,000 +94%
LGM
50
Logos Global Management
California
$7.44M +$7.44M +250,000 New
1
2
3 4 5